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Abstract
Background: Bronchiectasis is an incurable lung disease characterised by irreversible airway dilatation. It causes
symptoms including chronic productive cough, dyspnoea, and recurrent respiratory infections often requiring
hospital admission. Fatigue and reductions in quality of life are also reported in bronchiectasis. Patients often require
multi-modal treatments that can be burdensome, leading to issues with adherence. In this article we review the
provision of, and requirement for, education and information in bronchiectasis.
Discussion: To date, little research has been undertaken to improve self-management in bronchiectasis in comparison
to other chronic conditions, such as COPD, for which there has been a wealth of recent developments. Qualitative
work has begun to establish that information deficit is one of the potential barriers to self-management, and that
patients feel having credible information is fundamental when learning to live with and manage bronchiectasis.
Emerging research offers some insights into ways of improving treatment adherence and approaches to self-management
education; highlighting ways of addressing the specific unmet information needs of patients and their families who are
living with bronchiectasis.
Conclusions: We propose non-pharmacological recommendations to optimise patient self-management and symptom
recognition; with the aim of facilitating measurable improvements in health outcomes for patients with bronchiectasis.
Keywords: Bronchiectasis, Self-management, Information, Education, Qualitative, Adherence
Background
Bronchiectasis is a chronic lung condition that leads to a
significant symptom and treatment burden for those af-
fected, and significant costs to healthcare services such
as the National Health Service. Worldwide prevalence is
increasing [1–3], yet the evidence base for the manage-
ment of bronchiectasis remains poor [4, 5]. Historically,
there has been relatively little research conducted in this
field and it is only recently that more attention has been
paid to this previously somewhat neglected disease.
Improvements in disease management interventions in
bronchiectasis are required.
Interventions in bronchiectasis are likely to include
better medical therapies, yet it is also apparent that
bronchiectasis is a ‘model’ chronic disease in terms of its
potential for improvements in self-management. If pa-
tients and their carers know how to recognise symptoms
of deterioration or exacerbation, and know how and
when to take action, this could facilitate improvements
in self-management. This in turn has the potential to
promote disease stability, reductions in unscheduled pre-
sentations to acute health care services and improve-
ments in longer-term health.
Whilst clearly desirable, expecting patients to under-
stand their condition, the treatments used and the impli-
cations of not using them appropriately, is potentially
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challenging. Prior work has demonstrated that patients
with bronchiectasis feel more confident with their treat-
ments when they have received information about them
in a specialist clinic [6]. Not every patient with bronchi-
ectasis, however, has access to such information or
specialist expertise. Despite recommendations for educa-
tion and personalised management plans for patients
with bronchiectasis [4, 7], there remains a lack of infor-
mation material openly available to patients when com-
pared to other chronic medical and respiratory
conditions. For example, patients with chronic obstruct-
ive pulmonary disease (COPD) have a number of avail-
able resources [8–12]. In order to facilitate self-care,
patients need to have accurate and accessible information
about their condition, enabling them to recognise and re-
spond to triggers appropriately and understand how their
use of self-management could potentially alter their prog-
nosis. Suitable education could lead to a level of self-
management that results in clinically and biologically im-
portant endpoints in bronchiectasis. In this article we re-
view the need for education and information in
bronchiectasis and its current provision. We discuss op-
tions for future improvements in resource development to
facilitate much needed improvements in health outcomes.
The burden of bronchiectasis: symptoms, prevalence
and treatments
Bronchiectasis leads to symptoms of breathlessness,
cough and a chronic infective syndrome and conse-
quently, a poorer quality of life [13, 14] and clinically
significant fatigue [15, 16]. Patients often have recurrent
infective exacerbations, some of which result in costly
hospital admissions. Patients with bronchiectasis are at
an increased risk of anxiety and depression [17–19]. In
cystic fibrosis, depression and anxiety rates are higher
than in the general population, and therefore annual
screening is recommended [20, 21]. Given the potential
for such psychological distress to impact upon adher-
ence and disease management, annual screening in
bronchiectasis could also be of benefit. New data has
additionally shown a greater risk of coronary heart
disease and stroke in patients with bronchiectasis [22].
Multiple comorbidities are common in bronchiectasis
[23]. The burden of disease for patients and carers is
clearly significant.
The burden of bronchiectasis for healthcare services is
also significant. Recently, UK data reported a prevalence
of between 43.4/100,000 in those aged 18–30 and 1239.
7/100,000 in those aged 70–79 [1]. There is further evi-
dence that prevalence is increasing worldwide [2, 3].
Additionally, HRCT imaging studies report that up to
50% of patients with COPD have co-existent bronchiec-
tasis [24, 25] and it has been proposed that COPD and
bronchiectasis can co-exist as ‘bronchiectasis COPD
overlap syndrome’ (BCOS) [26]. With approximately
1,000,000 patients with a diagnosis of COPD in the UK
alone, [27] there is potential for the rise in prevalence of
both bronchiectasis and BCOS to continue.
Bronchiectasis mortality rates have been reported in
the UK as twice that of the general population [1], ap-
proximately 50% higher than that of uncomplicated
COPD (calculated at 3% per annum) and are increasing
[28, 29]. The presence of BCOS also leads to higher
mortality rates [30–32]. Prognosis varies in bronchiec-
tasis, with a study of 91 patients finding that the primary
cause of death was usually respiratory, with survival
rates of 91% at 4 years and 68.3% at 12.3 years [33]. The
same study found factors such as chronic infection with
Pseudomonas aeruginosa increase mortality. Two sever-
ity scores have been recently developed for use in bron-
chiectasis: the bronchiectasis severity index (BSI) [34]
and the FACED score [35]. Although both predict mor-
tality, the BSI is also predictive of severe exacerbations,
hospital admissions and quality of life [36, 37]. Infective
exacerbations lead to significant morbidity in bronchiec-
tasis. The British Thoracic Society (BTS) national bron-
chiectasis audit reported that 38% of patients had three
or more exacerbations per year [38]. Within cohorts of
patients across Europe, reported average exacerbation
rates have been from 1 to 4 per year [36, 39]. This is also
consistent with American data on the increasing burden
of bronchiectasis [40].
Earlier UK data also emphasised the burden of bron-
chiectasis, uncertainties in aetiology and lack of evidence
for the treatments that are often used [41]. Although
there are guidelines for investigation, diagnosis and
management of bronchiectasis produced by the BTS,
there is no cure for bronchiectasis and many therapies
are empiric and not evidence based [4]. Bronchiectasis
differs from some chronic diseases in both its periods of
exacerbation and the role patients may play in managing
these. In bronchiectasis, correct, timely recognition of
exacerbation symptoms and prompt, appropriate man-
agement of infections could lead to increased disease
stability. Failure to commence antibiotics promptly could
result in a more severe exacerbation of bronchiectasis,
potentially requiring hospital admission. This would lead
to significant additional healthcare costs, and a much
greater physical, psychological and social impact on pa-
tients and their families. Conversely, inappropriate and
excessive antibiotic use can lead to antibiotic resistance.
This could also have problematic repercussions in terms
of response to future treatments and consequently
longer-term health outcomes. Facilitating patients’ un-
derstanding and ability to self-manage is therefore ex-
tremely important.
With some exceptions, treatments are broadly similar
regardless of the aetiology of bronchiectasis, but specific
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treatment plans are tailored to the individual. These can
range from no regular treatments at all, to daily use of
nebulised therapies in conjunction with physiotherapy,
inhalers and oral medications that collectively can be
significantly complex and time-consuming for patients
and their families. There is evidence that adhering to in-
haled antibiotics decreases exacerbation rate and that
poor adherence is associated with poorer outcomes [42,
43]. Understanding the importance of a variety of treat-
ments can be problematic for patients and their families
and suitable information and education is required to
encourage adherence to mutually agreed treatment
plans. Importantly, it is known that those with more fre-
quent exacerbations suffer not only the physical effects,
but also a reduction in quality of life [14]. Measuring
how the psychological impacts and co-morbidities of
bronchiectasis affect treatment adherence and self-
management behaviours is a key challenge.
Current provision of information for patients with
bronchiectasis
The education of patients with bronchiectasis is recom-
mended; including explanations of the disease, recogni-
tion and importance of exacerbations, treatment
approaches and a personal management plan [4, 7]. Al-
though patients with bronchiectasis gain information
through discussion with their clinician, there is relatively
little additional information available to them in com-
parison to the number of resources available for other
chronic conditions such as COPD or Cystic Fibrosis.
When searching online for information about bronchiec-
tasis, there are resources available. Some are produced
by governmental bodies (e.g. the UK National Health
Service (NHS) and the US National Institutes of Health),
others by health information providers, and by hospitals
and charitable organisations [44–48]. However, in
addition to being limited in number when compared to
other conditions, many are either very brief, with limited
information provided, or are lengthy and potentially
overwhelming. There are some resources run by patients
which primarily serve as a patient’s view or online forum
rather than an information resource per se [49, 50]. To
date there are no high quality trials nor systematic re-
views of such information provision in bronchiectasis, as
conducted in COPD [8–12, 51].
A tabulated summary (Table 1) shows examples of
some of the bronchiectasis information resources that
are available online. Determining credibility (affiliation
with a well-known lung charity or a national healthcare
provider, for example) is a necessary step in the selection
process for patients seeking health information [52].
Despite the available information online, patients and
carers with bronchiectasis have reported a lack of trust-
worthy and user-friendly information and felt they
would benefit from credible, multi-format (text, images
and video content) resources that they could continue to
access outside of a clinic setting [53]. Further identifica-
tion of the unmet information needs of affected individ-
uals and preferred information formats would enable
appropriate resource development. A key priority is to
create an accessible, trustworthy resource containing in-
formation that users want, rather than information that
providers have decided patients should have.
Provision of information for chronic conditions:
General principles and its relationship to self-
management
The importance of information provision for patients
with long-term conditions and their carers is well recog-
nised. There is longstanding evidence that patients want
to access information [54] and that information can re-
duce anxiety [55] and improve patient outcomes [56,
57]. Self-management is increasingly recognised as an
important part of chronic disease management and is
recommended by the World Health Organisation
(WHO) [58]. Information provision is key to facilitating
self-care [59] and inadequacies in information provision
are a potential reason for people managing their health
poorly [60]. Information provision therefore plays an im-
portant role in supporting active participation in care
and remains a priority area of health research for all
chronic conditions.
Arguably, however, information alone does not always
translate into behavioural change [61]. Providing pa-
tients with a simple factsheet about their condition is
unlikely to result in any major tangible benefits. In a re-
view of the role of education in asthma, it was recog-
nised that information about asthma should not simply
be factual but allow patients to acquire skills [62]. It is
preferable to teach patients about their asthma treat-
ments and inflammation rather than the structure and
function of the lungs, for example [63]. Theoretical con-
structs and behavioural change techniques beyond infor-
mation delivery are important to consider in
development of any intervention that aims to produce
changes in behaviour [64, 65]. Framing information, by
establishing what is relevant to the patient group, and
how it could be delivered in order to achieve the desired
effects is therefore essential. For example, video demon-
strations or instructions on how to perform certain tasks
in bronchiectasis management such as chest clearance
has been identified by patients as a priority [53]. This
provision of instruction and demonstration of behav-
iours is in keeping with social-cognitive theory [66]. In-
formation on behaviour-health links and consequences
of actions or inactions, would be in keeping with an
information-motivation-behavioural skills model [67].
Information is an intervention, the production of which
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is a highly skilled process and ideally resources should
be user tested, co-designed and co-produced where pos-
sible [68]. Such an approach should be taken to resource
development for bronchiectasis [69].
Self-management and patient information provision
are seemingly inextricably linked. In primary care, self-
management has been referred to as ‘patients with
chronic disease making day to day decisions about their
illnesses’ [70] and ‘the everyday tasks and activities that
a person living with a chronic condition needs to carry
out’ [71]. The aim in supporting self-management is to
allow patients to gain not only the knowledge but also
the confidence and relevant skills to manage their condi-
tion; promoting patient ‘activation’ [72, 73]. An import-
ant concept embedded within this is self-efficacy: the
confidence that one can carry out a behaviour necessary
to achieve a desired goal [66]. Using self-efficacy as a
measurable outcome, however, is not without flaws, as
was shown when trialling the expert patient programme
(EPP) [74–76]. The EPP was initially developed for pa-
tients with arthritis and designed to enhance disease
specific information rather than replace it, as the
programme is generic in nature. Although these studies
found improvements in symptom control, pain and hos-
pitalisations as well as gains in self-efficacy, there are
some criticisms of the EPP. These include self-efficacy
gains not leading to improvements in self-management
and not necessarily reducing hospital presentations.
Additionally, it has been suggested that participants in
EPP studies were not representative of the general popu-
lation and were possibly better at self-managing than
most [77–79]. A UK study using a lay-led EPP (n = 629)
showed an increase in participant self-efficacy and en-
ergy, yet no reduction in health care utilisation [80].
A number of self-management educational resources
have been produced for chronic lung conditions other
than bronchiectasis. For example, SPACE for COPD, a
six week intervention [51]. At 6 months, there were
gains in disease knowledge, anxiety and performance
levels, yet the primary outcome measure of dyspnoea
had not improved [9]. Living Well with COPD [10] is a
website with information and videos requiring a pass-
word obtained by patients from their physician in order
to access the full material. A two year randomised con-
trolled trial conducted in primary care did not show
long term benefits over usual care when using measures
of self-efficacy and quality of life. The group with access
to the living well programme, however, did seem more
able to manage their exacerbations [81]. In asthma, a
study using an educational programme based on re-
peated short interventions (face to face sessions at
3 month intervals over 1 year, a personalised action plan
and inhaler technique training) saw improvements in
asthma control in the intervention group, yet a degree of
improvement within the control group was noted too
[82]. Cost effectiveness was not examined and although
the intervention was brief, it would involve staff time at
considerable cost, and there was no provision for patient
information needs at other time points.
Systematic reviews of such self-management education
in chronic lung disease have also been conducted. A re-
view of eight studies in COPD revealed inconclusive
evidence of any benefits [12]. A more recent review and
meta-synthesis, however, concluded that self-
management education could reduce hospital admissions
in COPD, and improve disease knowledge and quality of
life. It did not lead to reductions in mortality or smoking
rates, nor improve dyspnoea or lung function [11]. A re-
cent systematic review and meta-analysis across different
disease areas concluded that self-management interven-
tions can be implemented without a detrimental effect
on health outcomes and that they reduce service utilisa-
tion [57]. Although the effect sizes were small overall, it
is of note that respiratory conditions were amongst the
two groups that had the strongest evidence of benefit. In
asthma, a Cochrane review reported that self-
management education could improve health outcomes
only when delivered in conjunction with medical reviews
and a written action plan [83]. In cystic fibrosis, there
were too few data to draw firm conclusions about recom-
mendations for self-management [84]. In addition, a sep-
arate review of psychological interventions in cystic
fibrosis highlighted that behavioural interventions had
some effect in improving nutrition, and decision making
tools regarding transplantation improved knowledge and
expectations of transplant, yet there remained insufficient
evidence overall [85]. A protocol for a systematic review
of self-management in non-cystic fibrosis bronchiectasis
has recently been published [86]. Conclusions are likely to
be limited, however, reflecting the limited available litera-
ture on self-management in bronchiectasis.
Facilitating self-management in bronchiectasis:
Use of information and considerations for resource
development
An evidence-based intervention for use in bronchiectasis
is still needed. In a study using focus groups, patients
with bronchiectasis perceived lack of information and
confidence as barriers to self-management and felt that
disease specific information would be useful [87]. The
use of an EPP as part of a self-management programme
for patients with bronchiectasis has also been investi-
gated [88]. The programme consisted of two group ses-
sions of disease-specific information followed by a
standard, generic EPP for six weeks. Improvement was
found in six of ten domains of a self-efficacy scale, in-
cluding managing symptoms and depression. The inter-
vention group, however, also reported more symptoms
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and reduced quality of life post intervention. The educa-
tional sessions about bronchiectasis were not patient-
driven in terms of content or format of delivery, and
participants commented that the sessions should be con-
densed and be attended by physicians. Costs, staffing,
time and patient commitment involved with such a
course are considerable, making it potentially unfeasible
to deliver at scale within a clinical setting. A successful
intervention for bronchiectasis would need to meet pa-
tients’ needs, be easily accessible and be feasibly deliver-
able on a long-term basis.
Another recent study has taken a different approach
to aiding self-management in patients with bronchiec-
tasis, using a novel tool, the Bronchiectasis Empower-
ment Tool [89]. The tool consisted of a one page action
plan, within a pack containing information and optional
notepads. The reported aim of the study was to work
alongside existing care in order to improve self-
management. At the time of writing the study is closed
to recruitment but no published results are available.
In bronchiectasis, self-management includes making de-
cisions surrounding adherence to treatments. Factors
predicting adherence to treatments could include beliefs
about treatments and burden of treatment [90]. Based on
these findings, a theoretical approach is being used to
work towards development of a behaviour change inter-
vention to promote treatment adherence [91]. The need
for information was again reported by patients during in-
terviews. Participants thought that having knowledge
about bronchiectasis and treatments improved adherence.
There is evidence, in COPD, that gaps in knowledge of
health care professionals can impact upon patients’
knowledge and understanding of their condition [92].
This finding may apply to other conditions. Patients who
have bronchiectasis may not attend a specialist service,
and general physicians may have less disease-specific
knowledge than a specialist delivering a bronchiectasis
service. In addition, they may not have sufficient expos-
ure to have developed specific expertise in exchanging
disease-specific information in a patient-focussed man-
ner. Given this relative lack of exposure to patients who
have bronchiectasis, further development of such skills in
an area outside a healthcare providers’ area of main ex-
pertise is likely to be problematic. In exploratory inter-
views with patients who had bronchiectasis, [52]
participants referred to the fact that they had very little in-
formation until they started to attend a specialist bronchi-
ectasis clinic. A trustworthy and patient-driven resource
would enable both dissemination of good practice and
equity of information access amongst the patient group.
Information seeking is another important aspect to
consider in developing an understanding of patients’ in-
formation needs and how such needs are fulfilled. Trust,
particularly in relation to online resources, is a
recognised issue [93, 94]. Reasons identified for avoiding
seeking information in patients with bronchiectasis in-
clude not trusting sources, and fear of what they may
find [52]. The potential for information to worsen rather
than reduce anxiety has been proposed [95], and the
concept of information avoidance is recognised [96].
Reviews of health information seeking behaviour have
concluded that a better understanding of this concept
will enable the provision of better information, and that
information should meet patients’ individual needs [95,
96]. Previous work exploring why patients with cancer
may not want or seek information about their condition
also identified that patients’ attitudes and coping strat-
egies can limit their seeking of information [97]. The im-
portance of identifying the diversity of needs of the
patient group in order to tailor resources to suit them
rather than assume a ‘one size fits all’ approach will be
effective was additionally highlighted. Having an in
depth understanding of the information and education
needs of both patients and their families, and how these
could be met, in addition to an appreciation of how,
why and when patients seek information would appear
to be fundamental to the development and execution of
novel interventions in bronchiectasis. Understanding
these needs across a broad sample of potential users
with differing backgrounds, ages and disease severities,
for example, is also important. Those with bronchiec-
tasis aetiologies that are associated with additional
management challenges or poorer outcomes, for
example, non-tuberculous mycobacterium infections,
bronchiectasis-COPD overlap syndrome (BCOS) [26]
and bronchiectasis rheumatoid arthritis syndrome
(BROS) [98] may benefit from supplementary educa-
tional resources specific to their needs.
Patients use information to aid their decision making
about various aspects of their management. Carers are
often involved in shared decision-making in a variety of
different ways and patients are rarely entirely autono-
mous in these processes [99, 100]. The role of family or
carers in the adaptation of patients and coping with
chronic illness is very important [101, 102]. Carers are
just as likely to engage with information resources as pa-
tients. Therefore, any newly developed resource should
accommodate the needs of carers and families of pa-
tients with bronchiectasis in addition to patients. A
meta-synthesis of qualitative studies highlighted the im-
portance of social networks (family, friends, communi-
ties) in the self-management of chronic illnesses [103]. A
longitudinal study of patients with heart disease and dia-
betes also acknowledges this role of social networks in
supporting self-management [104]. Participation in com-
munity organisations (including online communities and
health education groups) has been associated with better
physical and mental health within the self-management
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of diabetes [105, 106]. It is apparent that when consider-
ing educational and self-management support interven-
tions they need to be tailored to users’ approaches.
Work has begun in bronchiectasis, as yet published
only in abstract form, to identify the unmet needs of pa-
tients and carers living with bronchiectasis, and co-de-
velop a multi-format information resource [53, 107]. A
feasibility study carried out using a resource developed
with users, based on their needs and experiences, in-
cluded user evaluations of the resource and web analyt-
ics [108]. A particular feature of this resource is the use
of video in information delivery, from professionals, pa-
tients and carers. This use of video was based on the
findings of prior qualitative interviews and was found to
be a particularly engaging aspect of the resource [69,
109]. The website (www.bronchiectasis.me) had over
27,000 worldwide views during the study period of
16 months. By delivering interventions that have been
designed in conjunction with patients, to complement
their learning approaches, information resources can be
tailored to meet needs and optimise uptake.
Conclusions
Patients and carers living with bronchiectasis have been
relatively poorly provided for in terms of health informa-
tion and self-management guidance, despite clear poten-
tial for such interventions to produce tangible benefits for
patients and health care service providers. The prevalence
of bronchiectasis is rising and makes this issue ever more
pressing. This lack of provision should be addressed with
a patient-centred approach, incorporating knowledge of
information seeking and self-management in both other
chronic diseases and bronchiectasis itself. In order to
achieve development of patient-driven and user-friendly
resources, the underlying needs and issues surrounding
information and its uptake for patients with bronchiectasis
must first be fully identified. The implementation of sys-
tematic annual screening for depression and anxiety could
also identify patients with requirements for additional psy-
chological support.
As with information delivered in a clinic setting, pa-
tients’ needs vary. By ensuring the involvement of di-
verse groups during co-development processes, this
range of views can be captured. By developing resources
with clearly labelled and sub-sectioned subject areas,
users can interact with the information they need, when
they need it, and avoid what they may not need or want
to know. Using healthcare experts across the multidis-
ciplinary team, patients and carers to co-produce high
quality information and education resources is an
important step towards facilitating self-management
advancements, improvements in adherence and conse-
quent physical and psychological health improvements
in bronchiectasis.
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